Antifungal susceptibility of bloodstream Candida isolates in Sfax hospital: Tunisia (Q39445046)

12 September 2017

title

Antifungal susceptibility of bloodstream Candida isolates in Sfax hospital: Tunisia (English)

1 reference

12 September 2017

A Sellami

1

1 reference

12 September 2017

H Sellami

2

1 reference

12 September 2017

S Néji

3

1 reference

12 September 2017

F Makni

4

1 reference

12 September 2017

S Abbes

5

1 reference

12 September 2017

F Cheikhrouhou

6

1 reference

12 September 2017

H Chelly

7

1 reference

12 September 2017

M Bouaziz

8

1 reference

12 September 2017

B Hammami

9

1 reference

12 September 2017

M Ben Jemaa

10

1 reference

12 September 2017

S Khaled

11

1 reference

12 September 2017

A Ayadi

12

1 reference

12 September 2017

publication date

19 December 2010

1 reference

12 September 2017

number of pages

6

1 reference

inferred from page(s)

published in

Mycopathologia

1 reference

12 September 2017

volume

171

1 reference

12 September 2017

issue

6

1 reference

12 September 2017

page(s)

417-422

1 reference

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

Candida dubliniensis: first identification in Sfax Hospital, Tunisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

Epidemiology of invasive candidiasis: a persistent public health problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

High rate of non-albicans candidemia in Brazilian tertiary care hospitals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

Epidemiology of candidemia in a tertiary care centre of north India: 5-year study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

Candida tropicalis fungemia in a tertiary care hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

Candida glabrata fungemia: experience in a tertiary care center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

Candidaemia in Europe: epidemiology and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

In vitro susceptibility to posaconazole of 1,903 yeast isolates recovered in France from 2003 to 2006 and tested by the method of the European committee on antimicrobial susceptibility testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

Candidemia due to Candida tropicalis: clinical, epidemiologic, and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-010-9388-0

Epidemiology, presentation, management and outcome of candidemia in a tertiary care teaching hospital in the United Arab Emirates, 1995-2001

21 January 2018

1 reference

12 December 2020

Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey

1 reference

12 December 2020

Candida species, genotypes and antifungal susceptibility of Candida isolates from blood samples of patients at the largest tertiary care hospital in Thailand during 1999-2002.

1 reference

12 December 2020

Susceptibility patterns of Candida species recovered from Canadian intensive care units

1 reference

12 December 2020

Nosocomial candidemia: risk factors and attributable mortality

1 reference

12 December 2020

Risk factors for candidemia-related mortality at a medical center in central Taiwan.

1 reference

12 December 2020

Predominance of Candida tropicalis bloodstream infections in a Singapore teaching hospital

1 reference

12 December 2020

10.1007/S11046-010-9388-0

Identifiers

DOI

1 reference

12 September 2017

1 reference